Zimmer Biomet Holdings (ZBH) Current Deferred Tax Assets (2009 - 2015)
Zimmer Biomet Holdings' (ZBH) quarterly Current Deferred Tax Assets came in at $365.8 million in Q3 2015, up 12.8% year-on-year from $324.3 million in Q3 2014, and down 4.86% quarter-over-quarter from $384.5 million in Q2 2015.
Zimmer Biomet Holdings (ZBH) Current Deferred Tax Assets (2009 - 2015) Analysis & Trends
Zimmer Biomet Holdings' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $365.8 million for Q3 2015.
- On a quarterly basis, Current Deferred Tax Assets rose 12.8% year-over-year to $365.8 million in Q3 2015; TTM through Sep 2015 was $365.8 million, a 12.8% increase from a year earlier, with the FY2014 full-year figure at $194.9 million, down 28.32% from the prior year.
- Current Deferred Tax Assets declined to $365.8 million in Q3 2015 per ZBH's latest filing, from $384.5 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $384.5 million in Q2 2015 and bottomed at $194.9 million in Q4 2014.
- The 5-year median for Current Deferred Tax Assets is $232.6 million (2011), against an average of $254.6 million.
- Biggest YoY gain for Current Deferred Tax Assets was 41.3% in 2014; the steepest drop was 28.32% in 2014.
- Year by year, Current Deferred Tax Assets stood at $210.5 million in 2011, then declined by 6.6% to $196.6 million in 2012, then jumped by 38.3% to $271.9 million in 2013, then retreated by 28.32% to $194.9 million in 2014, then soared by 87.69% to $365.8 million in 2015.
- Per Business Quant, the three latest ZBH Current Deferred Tax Assets figures stand at $365.8 million (Q3 2015), $384.5 million (Q2 2015), and $301.7 million (Q1 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 365.80 Mn |
| Sep 30, 2015 | 365.80 Mn |
| Jun 30, 2015 | 384.50 Mn |
| Jun 30, 2015 | 384.50 Mn |
| Mar 31, 2015 | 301.70 Mn |
| Mar 31, 2015 | 301.70 Mn |
| Dec 31, 2014 | 194.90 Mn |
| Dec 31, 2014 | 194.90 Mn |
| Sep 30, 2014 | 324.30 Mn |
| Sep 30, 2014 | 324.30 Mn |
| Jun 30, 2014 | 304.10 Mn |
| Jun 30, 2014 | 304.10 Mn |
| Mar 31, 2014 | 297.30 Mn |
| Mar 31, 2014 | 297.30 Mn |
| Dec 31, 2013 | 271.90 Mn |
| Dec 31, 2013 | 271.90 Mn |
| Sep 30, 2013 | 252.60 Mn |
| Sep 30, 2013 | 252.60 Mn |
| Jun 30, 2013 | 239.20 Mn |
| Jun 30, 2013 | 239.20 Mn |